The Scientific Advisory Team at Achillestx provides expert guidance on the development of personalized T cell therapies targeting neoantigens. They collaborate closely with research and development units to strategize and optimize therapeutic approaches, ensuring scientific rigor and innovation in the company's biopharmaceutical efforts.